{"id":"W2946988148","doi":"10.1016/j.lungcan.2019.05.027","title":"Immune checkpoint-inhibitors and chemoradiation in stage III unresectable non-small cell lung cancer","year":2019,"lang":"en","type":"review","venue":"Lung Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta; Juravinski Cancer Centre; McMaster University; Vancouver Hospital and Health Sciences Centre; University of Toronto; Princess Margaret Cancer Centre; BC Cancer Agency","funders":"Merck Canada; AstraZeneca Canada","keywords":"Durvalumab; Medicine; Oncology; Lung cancer; Pneumonitis; Internal medicine; Chemoradiotherapy; Context (archaeology); Clinical trial; Adverse effect; Cancer; Nivolumab; Immunotherapy; Lung","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004605832,0.0006607216,0.002214323,0.0003868545,0.00007526828,0.00006578476,0.0002132628,0.0005705963,0.001028297],"category_scores_gemma":[0.00001294731,0.000557395,0.0005076759,0.0007367854,0.00007146882,0.000139702,0.0000979864,0.000774708,0.000009592742],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002243098,"about_ca_system_score_gemma":0.001988516,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01291715,"about_ca_topic_score_gemma":0.001328412,"domain_scores_codex":[0.9970784,0.00007805041,0.00105138,0.0008040688,0.0003348756,0.0006532174],"domain_scores_gemma":[0.998409,0.00008638139,0.0006674338,0.0006101114,0.00008152048,0.0001455829],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001045283,0.0001995743,0.006251302,0.2055213,0.00140633,0.00006647737,0.001133825,0.00002670913,0.001609161,0.00000422905,0.008115609,0.7746202],"study_design_scores_gemma":[0.005657716,0.00009173268,0.0007077192,0.04159258,0.001886907,0.00001132162,0.00006515613,0.0004949918,0.0008500402,4.111646e-7,0.9478544,0.0007870218],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003723207,0.9889057,0.0000080272,0.0001349767,0.001745922,0.003221142,0.0001642893,0.00004654265,0.002050208],"genre_scores_gemma":[0.0004875466,0.9726162,0.0000359702,0.0001620568,0.0007264881,0.0009556658,0.0001728803,0.0001521223,0.02469107],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9397388,"threshold_uncertainty_score":0.9998849,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01980405145998392,"score_gpt":0.3242405323665668,"score_spread":0.3044364809065829,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}